{"title":"改善b细胞表位预测。","authors":"Hao Yu, Diane Joseph-McCarthy, Sandor Vajda","doi":"10.1016/j.drudis.2025.104489","DOIUrl":null,"url":null,"abstract":"<p><p>The prediction of antibody binding residues of an antigen is essential for understanding the immune response mechanisms and advancing antibody therapeutics. By definition, each epitope is the binding site of a specific antibody; however, many prediction methods are antibody-agnostic, and thus need only the structure of the antigen. Antibody-specific methods also require either the structure or models of the antibody, and are generally based on docking or co-folding algorithms. Machine learning methods have been improved substantially during the last few years, resulting in new approaches to epitope prediction. We evaluate some popular methods and show that combining AlphaFold 3 with the epitope prediction program AbEMap yields substantially better results than any of the other methods tested.</p>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":" ","pages":"104489"},"PeriodicalIF":7.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving B-cell epitope prediction.\",\"authors\":\"Hao Yu, Diane Joseph-McCarthy, Sandor Vajda\",\"doi\":\"10.1016/j.drudis.2025.104489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The prediction of antibody binding residues of an antigen is essential for understanding the immune response mechanisms and advancing antibody therapeutics. By definition, each epitope is the binding site of a specific antibody; however, many prediction methods are antibody-agnostic, and thus need only the structure of the antigen. Antibody-specific methods also require either the structure or models of the antibody, and are generally based on docking or co-folding algorithms. Machine learning methods have been improved substantially during the last few years, resulting in new approaches to epitope prediction. We evaluate some popular methods and show that combining AlphaFold 3 with the epitope prediction program AbEMap yields substantially better results than any of the other methods tested.</p>\",\"PeriodicalId\":301,\"journal\":{\"name\":\"Drug Discovery Today\",\"volume\":\" \",\"pages\":\"104489\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.drudis.2025.104489\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.drudis.2025.104489","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
The prediction of antibody binding residues of an antigen is essential for understanding the immune response mechanisms and advancing antibody therapeutics. By definition, each epitope is the binding site of a specific antibody; however, many prediction methods are antibody-agnostic, and thus need only the structure of the antigen. Antibody-specific methods also require either the structure or models of the antibody, and are generally based on docking or co-folding algorithms. Machine learning methods have been improved substantially during the last few years, resulting in new approaches to epitope prediction. We evaluate some popular methods and show that combining AlphaFold 3 with the epitope prediction program AbEMap yields substantially better results than any of the other methods tested.
期刊介绍:
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.